Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03709693 · ClinicalTrials.gov registry record
Clinical Outcomes in Patients Treated With SternaLock Blu
A clinical trial, sponsored by Zimmer Biomet.
- Terminated
- Registry status
- 156
- Enrollment target
NCT03709693 is a clinical trial that was terminated before completion, run by Zimmer Biomet. The registered enrollment target is 156 participants.
The verdict
NCT03709693 was terminated before completion, sponsored by Zimmer Biomet.
- TERMINATED
- Registry status
- 156 participants
- Enrollment target
Study Summary
The primary objective of this study is to evaluate the rate of deep sternal wound infection at 30 days post-operative following a full median sternotomy in patients treated with SternaLock Blu for rigid sternal fixation. This study will also provide evidence of the clinical performance of SternaLock Blu for up to 90 days using real world evidence methodology. Sternal complications will be reported through 90 days follow up.
Interventions
- DEVICE SternaLock Blu
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 156 participants |
| Start Date | 2019-05-14 |
| Est. Completion | 2020-05-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03709693
The ClinicalTrials.gov registry entry for NCT03709693 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 156 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zimmer Biomet, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SternaLock Blu is the first listed.
NCT03709693 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03709693 about?
NCT03709693 is a clinical study titled "Clinical Outcomes in Patients Treated With SternaLock Blu". The primary objective of this study is to evaluate the rate of deep sternal wound infection at 30 days post-operative following a full median sternotomy in patients treated with SternaLock Blu for rigid sternal fixation. This study will also provide evidence of the clinical performance of SternaLock...
What is the current status of trial NCT03709693?
This trial is currently terminated. The enrollment target is 156 participants. The study started on 2019-05-14. Estimated completion is 2020-05-13.
What interventions are being tested in trial NCT03709693?
The interventions under investigation include: SternaLock Blu (DEVICE).
Who is sponsoring clinical trial NCT03709693?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.